• OPEN AN ACCOUNT
Indian Indices
Nifty
24,328.95 161.70
(0.67%)
Sensex
80,116.49 520.90
( 0.65%)
Bank Nifty
55,370.05 -277.15
( -0.50%)
Nifty IT
35,414.65 1,473.60
( 4.34%)
Global Indices
Nasdaq
39,204.12 1,012.71
(2.65%)
Dow Jones
5,307.94 128.74
(2.49%)
Hang Seng
34,813.34 592.74
(1.73%)
Nikkei 225
8,403.18 74.58
(0.90%)
Forex
USD-INR
85.15 -0.16
(-0.19%)
EUR-INR
98.05 0.84
(0.87%)
GBP-INR
113.94 0.53
(0.47%)
JPY-INR
0.60 0.00
(0.76%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
98.3315118
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
133.07
419223.8
EPS(TTM)
Face Value()
Div & Yield %
13.13
1
0.77
 

As on: Apr 23, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,788.90 41.65 19562 133.07
Stock Price Details
Open Price() 1,757.20
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,792.00
Today's Low () 1,742.85
52-Week High () 1960.2
152-Week Low () 1376.75
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.77
Eps 13.13
Book Value 98.3315118
Market Cap (.Cr) 419,223.80
Face Value 1
Market Lot 1
AGM Date Aug
Book Closure Date
ISIN No. INE044A01036


News
Sun Pharmaceutical Industries Ltd - Sun Pharmaceutical Industries Limited - Updates
Sun Pharma receives favourable ruling in preliminary injunction delaying launch of LEQSELVI™
Sun Pharmaceutical launches Fexuprazan tablets 40 mg in India
Sun Pharma launches Fexuprazan tablets 40 mg in India
Sun Pharmaceutical Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sun Pharmaceutical Industries Ltd - Sun Pharmaceutical Industries Limited - Press Release
Sun Pharmaceutical Industries Ltd - Sun Pharmaceutical Industries Limited - Press Release
Sun Pharmaceutical Industries Ltd - Sun Pharmaceutical Industries Limited - Updates
Sun Pharmaceutical Industries Ltd - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Update On Our Investee Company
Sun Pharma completes acquisition of Antibe Therapeutics Inc., Canada
More
Corporate Details
Incoporation Year   : 1993
Chairman : Dilip S Shanghvi
Bussiness Group : Sun Pharma
Registered Office
Sun Pharmaceutical Industries Ltd
Sun Pharma Advanced Res.Centre,
Tandalja,
Vadodara,
Gujarat-390020
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-265-6615500
Fax:91-265-2354897
Fax:91-22-66317458
E-Mail : secretarial@sunpharma.com
URL : http://www.sunpharma.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE SENSEX
  • BSE 100
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE GREENEX
  • bse carbonex
  • NIFTY
  • CNX 500
  • CNX 100
  • CNX Pharma
  • CNX 200
  • NI15 Index
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi